Formulation and Drug Delivery

AstraZeneca’s Antibody Combination Authorized for Use in Great Britain for Prevention of COVID-19

March 21, 2022

AstraZeneca’s antibody combination has been authorized for use in Great Britain to prevent COVID-19 in high-risk populations and people for whom vaccination may not be effective.

Moderna and the Japanese Government Reach an Agreement to Supply Japan with Additional 70 Million Doses of Moderna’s COVID-19 Booster Vaccine

March 21, 2022

Moderna has reached an agreement with the Ministry of Health, Labor, and Welfare of Japan (MHLW) to supply Japan with an additional 70 million doses of its COVID-19 Booster Vaccine.

physIQ and CellCarta Collaborate on Personalized Approach to Vaccine Development

March 21, 2022

physIQ and CellCarta are conducting a study to evaluate individual patient response to vaccination using wearable biosensors.

Sanofi Announces €300 million Collaboration with Blackstone Life Sciences to Advance a Treatment for Multiple Myeloma

March 18, 2022

Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.

EMA Recommends Updated Product Information for Moderna and Janssen COVID-19 Vaccines

March 16, 2022

EMA has recommended that possible side effects of Spikevax and Janssen COVID-19 vaccines be added to product information.

NIH Launches Clinical Trial of Three mRNA HIV Vaccines

March 16, 2022

NIH has launched one of the first Phase 1 clinical trials to examine mRNA technology for HIV.

Novo Nordisk Expands Research Collaboration in Novel Delivery Technologies for Biologic Medicines

March 10, 2022

Novo Nordisk will expand its existing research collaboration in novel delivery technologies with MIT and Brigham and Women’s Hospital.

Evonik Launches New EUDRATEC Technology to Improve Solubility of Oral Small Molecules

March 10, 2022

Evonik has launched new EUDRATEC technology to improve solubility and performance of oral small molecules.

Johnson & Johnson COVID-19 Vaccine to be Manufactured in Africa

March 08, 2022

Johnson & Johnson have announced a landmark agreement to enable the manufacturing and availability of its COVID-19 vaccine in Africa by an African company.

Moderna to Establish its First mRNA Manufacturing Facility in Africa

March 08, 2022

Moderna has announced that it has entered a Memorandum of Understanding with the government of the Republic of Kenya to establish its first mRNA manufacturing facility in Africa.